secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-204999
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix Q1 pro forma revenue $196.4M +2.7% constant currency; reaffirms FY guidance
--------------------------------------------------------------------------------

- GAAP net loss $(20.9)M vs $(53.1)M prior year; adjusted EBITDA $9.7M (4.9% of pro forma sales) vs $11.4M (6.0%) prior year.
- Global Spine Fixation +6%, Therapeutic Solutions +5%, Limb Reconstruction +10% reported (+3% constant currency).
- Reaffirms FY2026 net sales $850M-$860M, adjusted EBITDA $95M-$98M, positive free cash flow.
- Cash $120.9M at March 31, 2026; plans to repay $424M 0.875% exchangeable notes due June 2026.
- Distributor transitions largely behind; expects improved commercial execution and product launches later in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000119312526204999/0001193125-26-204999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000119312526204999/ofix-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-204999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer